Gallus is capitalizing on the extraordinary flexibility afforded by both disposable and flexible stainless steel technologies along with the extensive manufacturing experience of Gallus's team, to provide innovative solutions for established as well as development-stage biopharmaceutical companies.
Gallus’ facility in St. Louis has over 30,000 square feet of lab space for process development and cGMP clinical and commercial manufacturing of mammalian cell culture-based biopharmaceuticals. All of our manufacturing suites are designed with a high degree of flexibility to meet clients’ needs with optimum efficiency. From modular capacity that can be custom built to clients’ specification, to options on the latest fully disposable or flexible stainless steel technology, and a selection of business models that bring varying advantages, Gallus has one of the most flexible contract manufacturing offerings. We’re one of very few CMOs with a strong track record of mammalian cell culture and protein purification in batch, fed batch and perfusion modes. And we’re a pure-play CMO, ensuring all of our focus and efforts are on our clients’ projects.